Clinical manifestations of thrombosis, that is, stroke and/or VTE, and/or obstetric complications according to Miyakis et al,15 with the modification that we only required aPL-positivity on one occasion, as many patients lacked repeated measurements. This evidence concerns the gene FASLG and Stroke.